Baricitinib and Infliximab Mitigate the Endothelial-to-Mesenchymal Transition (EndMT) Induced by Cytokines in HUVECs.
Saved in:
| Title: | Baricitinib and Infliximab Mitigate the Endothelial-to-Mesenchymal Transition (EndMT) Induced by Cytokines in HUVECs. |
|---|---|
| Authors: | Barilli, Amelia1 (AUTHOR), Visigalli, Rossana1 (AUTHOR), Recchia Luciani, Giulia1 (AUTHOR), Crescini, Eleonora1 (AUTHOR), Dall'Asta, Valeria1 (AUTHOR) valeria.dallasta@unipr.it, Rotoli, Bianca Maria1 (AUTHOR) |
| Source: | International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 17, p8672. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms26178672 |